S&P 500 Introduction 2022 has been a bad year price-wise for the stock market as measured by the S&P 500. However, I contend that is not enough to simply know that the market is down, it is even more important to know why. Nevertheless, as you read this my guess would be that several thoughts …
AbbVie
Pharma and Biotech Stocks On Sale
Introduction Pharma & Biotech Subscriber Request Series: 5 Biotechnology (biotech) and 2 Pharmaceutical (pharma) Companies on sale. Each Tuesday I cover stocks that have been requested from our channel’s YouTube subscribers. This week I covered pharmaceutical giant Merck (MRK) and the much smaller company in transition Teva Pharmaceutical (TEVA). In the biotechnology subindustry I covered …
$ABBV AbbVie Has It All: Growth, Dividend Growth and Compelling Valuation (NYS:ABBV)
Introduction I have held AbbVie (ABBV) since it was originally spun off from Abbott Labs. Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth. All in all, it has been an excellent performer in spite of the fact that it is being ridiculously undervalued by Mr. Market. …